Assessing efficacy of an autologous protein solution injection versus saline for knee osteoarthritis
Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled TrialAm J Sports Med. 2018 Jan;46(1):171-180.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
46 patients with Kellgren-Lawrence grade II-III knee osteoarthritis were randomized in a 2:1 fashion to intraarticular injection of either the Autologous Protein Solution blood product (nSTRIDE APS; Biomet Zimmer) or placebo saline. Patients were assessed for clinical measures and imaging results over a 12-month follow-up. For pain, the WOMAC pain score demonstrated favourable improvement in the A...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE